Navigation Links
MagSense to Exhibit Its Scientific and Clinical Applications at International Magnetic Carriers Conference
Date:5/19/2008

VANCOUVER, British Columbia, May 19 /PRNewswire/ -- MagSense Life Sciences Inc, a leading developer and manufacturer of magnetic separation technologies, announced it will be participating in the 7th International Conference on the Scientific and Clinical Applications of Magnetic Carriers, being held May 21-24, 2008 in Vancouver, BC, Canada.

This conference is devoted to the preparation, analysis, use and application of magnetic microsphere and nanoparticles in basic and clinical research. MagSense will share its insights on the application of superparamagnetic particle technologies in biological research, diagnostics and drug development.

"At this conference, we'll discuss how our unique particles make it possible to perform demanding separations from large-volume and high-viscosity solutions such as serum or whole blood where efficiency matters," said Hao Shang, principal scientist at MagSense. "This efficiency is essential to saving valuable time and money while delivering positive results."

MagSense designs, manufactures and markets magnetic separation technologies, such as superparamagnetic particles. The company enables researchers to attain high-purity biomolecules through the application of magnetic separation technologies. These are highly reliable, convenient, and cost-effective alternatives to more traditional bioseparation methods. About

MagSense Life Sciences

Headquartered in West Lafayette, IN., MagSense Life Sciences, Inc, develops, manufactures, and markets magnetic separation technologies for life sciences research and biochemical production. The enhanced magnetic properties and uniformity of its superparamagnetic microparticles are ideally suited for pharmaceutical, biotechnology, and diagnostics companies, as well as research centers and laboratories of academic, government, and private foundations in the global market. Superparamagnetic microparticle applications include affinity separations (such as, the
'/>"/>

SOURCE MagSense Life Sciences Inc
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Varian Medical Systems Exhibits Latest Technologies and Products Designed to Improve Speed and Precision of Radiotherapy at ESTRO 2007
2. An Uncommon Eye: Photography Exhibit by Biotechnology Executive at BHCC Gallery
3. MedImmune to Present RSV Surveillance and Cost-Effectiveness Data at American Academy of Pediatrics National Conference & Exhibition
4. Imaging Diagnostic Systems Exhibits CT Laser Breast Imaging Results at Major Italian Multidisciplinary Breast Cancer Meeting
5. ABR-Affinity BioReagents to Exhibit at ASCB in Washington D.C., December 1 - 5, 2007
6. Kiwa Bio-Tech Products Group Holds a Fertilizer Products Exhibition in Hebei
7. Imaging Diagnostic Systems Exhibits at Major Middle East Health Conference
8. Maryland Science Center Unveils Anatomical Exhibition, Body Worlds 2, on Saturday, February 2
9. West Michigan Science & Technology Initiative Seeks Exhibitors for Annual Life Science Showcase
10. BioInformatics, LLC Studies Trade Show Exhibition Strategies in the Life Science Market
11. Biotechnology Leader to Exhibit at Upcoming Trade Show
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... Arbor, Mich. Every day, their baby stopped breathing, ... to his lungs. April and Bryan Gionfriddo watched helplessly, ... , "Quite a few doctors said he had a ... April Gionfriddo, about her now 20-month-old son, Kaiba. "At ... we would take it and run with it." , ...
(Date:5/23/2013)... , May 23, 2013  BioScrip, Inc. (NASDAQ: ... present at the Jefferies 2013 Global Healthcare Conference to ... New York. Richard Smith ... Hai Tran , Chief Financial Officer, will present ... Daylight Time.   About BioScrip BioScrip, ...
(Date:5/23/2013)... (PRWEB) May 23, 2013 Graphite ... self-lubricating bushings mounted in stainless steel pillow ... properties of GRAPHALLOY with the application and installation ... Steel Pillow Blocks work exceptionally well when ... or hostile liquids such as acids, alkalies, hydrocarbons, ...
(Date:5/23/2013)... 2013 PuraMed BioScience ® , Inc., ... over-the-counter (OTC) medicinal and healthcare products, announced that ... company based on low market capitalization valuation. ... Natural Product to Treat Migraine Headaches , ... Competitor , Currently Available Nationwide at Walgreen,s ...
Breaking Biology Technology:Baby's life saved with groundbreaking 3-D printed device that restored his breathing 2Baby's life saved with groundbreaking 3-D printed device that restored his breathing 3Graphite Metallizing Now Offers GRAPHALLOY® Stainless Steel Pillow Blocks for Success in Submersible Applications 2Graphite Metallizing Now Offers GRAPHALLOY® Stainless Steel Pillow Blocks for Success in Submersible Applications 3PuraMed BioScience (PMBS) Issued Alert Based on Market Cap of $721,756 2PuraMed BioScience (PMBS) Issued Alert Based on Market Cap of $721,756 3
... , , ... that it has entered into a cooperative research and development ... (NIAID), part of the National Institutes of Health (NIH), to ... mycobacteria (NTM) lung infections. , , Transave ...
... BEIJING, July 30 /PRNewswire-Asia-FirstCall/ -- Lotus Pharmaceuticals, ... a growing developer and,producer of prescriptions drugs and ... Republic of China, today reported it received notice,of ... of the People,s,Republic of China for its innovative ...
... Dendreon Corporation (Nasdaq: DNDN ) management will host a conference call on ... quarter 2009 financial results. Access to the discussion may be obtained as follows: ... 11:30 AM ET /8:30 AM PT, Date: ... or +1-719-325-4873 (international), Webcast: www.dendreon.com (homepage and investor relations ...
Cached Biology Technology:Transave Enters Into Cooperative Research Agreement With NIH To Study ARIKACE(TM) In Nontuberculous Mycobacteria 2Transave Enters Into Cooperative Research Agreement With NIH To Study ARIKACE(TM) In Nontuberculous Mycobacteria 3Transave Enters Into Cooperative Research Agreement With NIH To Study ARIKACE(TM) In Nontuberculous Mycobacteria 4Lotus Pharmaceuticals, Inc. Announces Patent Pending Gliclazide-Controlled Release Tablets 2Lotus Pharmaceuticals, Inc. Announces Patent Pending Gliclazide-Controlled Release Tablets 3Dendreon to Hold Conference Call on Tuesday, August 11, 2009 at 11:30 AM ET 2
(Date:5/23/2013)... year, carrying more than 284 million tons of cargo, transit ... in toll fees for the Panama Canal Authority. Each time ... water are used from Gatun Lake, which is also a ... the isthmus. , However, the advent of very large ... ships at sea, has demanded change. The Panama Canal is ...
(Date:5/23/2013)... which estrogen suppresses lipid synthesis in the liver, UC ... treating certain liver diseases. , With this finding, ... long-held views in the field. Study results appear in ... Signaling . , "The dogma in the steroid receptor ... located in the nucleus respond to steroid hormones by ...
(Date:5/23/2013)... overall health, development, and academic success of children, ... that all students have opportunities to engage in ... or moderate-intensity physical activity, says a new report ... suggest that only about half of school-age children ... and development. The report recommends that most ...
Breaking Biology News(10 mins):Reforestation study shows trade-offs between water, carbon and timber 2Reforestation study shows trade-offs between water, carbon and timber 3UCI study reveals new mechanism for estrogen suppression of liver lipid synthesis 2Schools should provide opportunities for 60 minutes of daily physical activity to all students 2Schools should provide opportunities for 60 minutes of daily physical activity to all students 3
... eyes are closed, the visual centers in our brain are ... in the last few years that the magnitude of sense-related ... is quite similar to that of one exposed to a ... of that activity, explaining why, even though our sense centers ...
... ESA is now gearing up to return to Russia to ... now envisaged for launch on 16 March 2009. This follows ... Rockot launcher that delayed the launch of GOCE by Eurockot ... has just arrived at the Plesetsk Cosmodrome in northern Russia ...
... at Albert Einstein College of Medicine of Yeshiva University have ... and causes disease. The study, published in ... ( PNAS ), may help scientists develop new therapies ... These fungal infections occur most commonly in those with compromised ...
Cached Biology News:Behind closed eyes 2March launch planned for ESA's gravity mission 2Scientists discover how deadly fungus protects itself 2
... A very potent Rnase free ... over a broad range of ... protein does not inhibit SP6, ... AMV and M-MLV reverse transcriptase ...
... kit, 110 to 220 V, enables ... doubles flow rates and valve capacity ... kit includes the Maximizer base unit, ... tubing kit, system cable 30, and ...
Mouse monoclonal antibody to QDPR - quinoid dihydropteridine reductase...
Mouse polyclonal antibody to QDPR - quinoid dihydropteridine reductase...
Biology Products: